Melissa S. Flores
Known title: SVP, CHROCIK: 0001842788
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
IDEX price target raised to $285 by RBC Capital. RBC Capital has kept its outperform rating on IDEX and lifted the target price to $285, reflecting confidence in the company's earnings outlook. The move comes as the stock trades near the upper end of its 52‑week range and shows a moderately strong RSI of 63.3. Analysts see the firm’s valuation as still attractive compared to peers. The update may influence how investors view IDEX’s growth prospects.
Transaction History
| IP | ▲ Buy | Grant | 24,845 | $0 | 1/5/2026 | View on chart |
| IEX | ▲ Buy | Grant | 865 | $0 | 2/20/2025 | View on chart |
| IEX | ▲ Buy | Grant | 777 | $153K | 2/11/2025 | View on chart |
| IEX | ▼ Sell | Tax Withholding | 377 | $74K | 2/11/2025 | View on chart |
| IEX | ▼ Sell | Tax Withholding | 205 | $47K | 2/13/2024 | View on chart |
| IEX | ▲ Buy | Grant | 413 | $94K | 2/13/2024 | View on chart |
| IEX | ▼ Sell | Tax Withholding | 137 | $32K | 2/21/2023 | View on chart |
| IEX | ▲ Buy | Grant | 537 | $124K | 2/18/2023 | View on chart |
| IEX | ▼ Sell | Tax Withholding | 264 | $61K | 2/18/2023 | View on chart |
| IEX | ▼ Sell | Tax Withholding | 69 | $13K | 3/1/2022 | View on chart |
| IEX | ▲ Buy | Grant | 301 | $58K | 2/16/2022 | View on chart |
| IEX | ▼ Sell | Tax Withholding | 105 | $20K | 2/16/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
International Paper (IP) faces valuation dip and EMEA business review
The stock has fallen about 23% and is now considered below fair value by analysts. Management is reviewing options for its EMEA packaging business, including possible offers. Recent trading saw the shares move higher, reflecting the ongoing discussion of the strategic review. The situation adds focus on valuation and the outcome of the EMEA decision.
International Paper (IP) faces valuation dip and EMEA business review. The stock has fallen about 23% and is now considered below fair value by analysts. Management is reviewing options for its EMEA packaging business, including possible offers. Recent trading saw the shares move higher, reflecting the ongoing discussion of the strategic review. The situation adds focus on valuation and the outcome of the EMEA decision.